Niquitin Omega Pharma (Nicotine)

Nicotine, the active ingredient in Niquitin Omega Pharma, is a nicotinic receptor agonist presented as an unspecified strength/oromucosal form for oromucosal use. It is employed to aid smoking cessation in adults who are dependent on nicotine and seeking to quit tobacco through a regulated cessation program.

GNH USA supplies Niquitin Omega Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. Our global network ensures reliable delivery, quality assurance, and regulatory compliance for each shipment. We adhere to stringent standards to support patient care across regions.

Nicotine acts on nicotinic acetylcholine receptors to facilitate smoking cessation.

- Smoking cessation: reduces withdrawal symptoms and cravings, helping adults quit tobacco use. - Nicotine dependence: supports gradual reduction of nicotine intake in individuals attempting to stop smoking. - Tobacco use disorder: assists in managing cravings and improving abstinence rates during cessation programs.

Nicotine replacement therapy may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Headache - Dizziness

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiovascular events such as chest pain or arrhythmia - Seizures - Significant hypotension

When prescribing nicotine for smoking cessation, several safety considerations should be observed.

- Cardiovascular assessment: evaluate patients with recent myocardial infarction or uncontrolled hypertension before use. - Pregnancy and lactation: avoid unless benefits outweigh potential risks, as safety data are limited. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Psychiatric conditions: monitor for worsening anxiety or depression during therapy. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Nicotine may interact with other medicines, altering their effects or increasing adverse risk.

Major Interactions (Avoid): - Concurrent use of other nicotine replacement products: may cause nicotine overdose. - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive crisis. - Beta‑blockers: nicotine can reduce their antihypertensive efficacy.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance stimulant effects, leading to jitteriness. - Alcohol: combined use can increase cardiovascular strain. - Antidepressants (SSRIs): monitor for altered mood or anxiety levels.